Related Experiment Video
Updated: Mar 16, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Splicing-factor alterations in cancers
Olga Anczuków1, Adrian R Krainer1
1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA.
Abstract:
Tumor-associated alterations in RNA splicing result either from mutations in splicing-regulatory elements or changes in components of the splicing machinery. This review summarizes our current understanding of the role of splicing-factor alterations in human cancers. We describe splicing-factor alterations detected in human tumors and the resulting changes in splicing, highlighting cell-type-specific similarities and differences. We review the mechanisms of splicing-factor regulation in normal and cancer cells. Finally, we summarize recent efforts to develop novel cancer therapies, based on targeting either the oncogenic splicing events or their upstream splicing regulators.
Insights
Alterations in RNA splicing factors are common in human cancers, affecting gene expression. This review explores these splicing factor changes, their mechanisms, and potential therapeutic strategies targeting cancer splicing events.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Tumorigenesis involves alterations in RNA splicing.
- Splicing factor changes can arise from mutations or machinery disruptions.
Purpose of the Study:
- To review the role of splicing-factor alterations in human cancers.
- To discuss mechanisms of splicing regulation in normal and cancerous cells.
- To explore novel therapeutic strategies targeting cancer splicing.
Main Methods:
- Literature review of splicing-factor alterations in human tumors.
- Analysis of splicing changes and their cell-type specificities.
- Examination of splicing factor regulation mechanisms.
Main Results:
- Splicing-factor alterations are detected across various human tumors.
- These alterations lead to significant changes in RNA splicing patterns.
- Cell-type specificities in splicing alterations and outcomes are highlighted.
Conclusions:
- Splicing factor alterations are a key feature of human cancers.
- Understanding these alterations provides insights into cancer development.
- Targeting oncogenic splicing events offers promising therapeutic avenues.
Related Concept Videos
RNA Splicing
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Pre-mRNA Processing: RNA Splicing

